Impact of febuxostat on visit-to-visit blood pressure variability: insights from the randomised PRIZE Study

OBJECTIVES: Although uric acid lowering therapies, including xanthine oxidase (XO) inhibition, may reduce the absolute level of blood pressure (BP), the effect of XO inhibition on BP variability is largely unknown. The aim of the present analysis was to evaluate the impact of febuxostat, an XO inhib...

Descripción completa

Detalles Bibliográficos
Autores principales: Saito, Yuichi, Tanaka, Atsushi, Koide, Yuji, Yoshida, Hisako, Uchida, Daigaku, Matsunaga, Kazuo, Yokota, Naoto, Ueyama, Chikara, Kobayashi, Yoshio, Node, Koichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Miscellaneous
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478834/
https://www.ncbi.nlm.nih.gov/pubmed/36109083
http://dx.doi.org/10.1136/rmdopen-2022-002505

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478834/
https://www.ncbi.nlm.nih.gov/pubmed/36109083
http://dx.doi.org/10.1136/rmdopen-2022-002505

Ejemplares similares